User contributions
Jump to navigation
Jump to search
- 19:32, 17 July 2023 diff hist +729 Neuroblastoma →References
- 19:28, 17 July 2023 diff hist -62 Neuroblastoma →Supportive Therapy, Cycle 8
- 19:27, 17 July 2023 diff hist -62 Neuroblastoma →Regimen variant #1, Group 2 patients > 12 kg {{#subobject:c79417|Variant=1}}
- 19:26, 17 July 2023 diff hist +16,159 Neuroblastoma →COG ANBL0531
- 14:49, 17 July 2023 diff hist -15 Neuroblastoma →COG A3961
- 14:49, 17 July 2023 diff hist -17 Neuroblastoma →References
- 14:48, 17 July 2023 diff hist -62 Neuroblastoma →Regimen Variant #6, Course 1 and 2 Weight Based Dosing for children < 60 days of age {{#subobject:c71517|Variant=1}}
- 14:48, 17 July 2023 diff hist -58 Neuroblastoma →References
- 14:47, 17 July 2023 diff hist +75 Neuroblastoma →References
- 14:46, 17 July 2023 diff hist +32 Neuroblastoma →Intermediate-risk, all lines of therapy
- 14:44, 17 July 2023 diff hist +669 Neuroblastoma →COG P9641
- 14:35, 17 July 2023 diff hist +12,715 Neuroblastoma →Low-risk
- 19:47, 10 April 2023 diff hist +634 Hepatoblastoma →References
- 01:42, 10 April 2023 diff hist +7,454 Hepatoblastoma →High-risk, upfront therapy
- 01:41, 10 April 2023 diff hist +3,261 Hepatoblastoma
- 22:35, 27 February 2023 diff hist -85 Editing test page 2
- 22:34, 27 February 2023 diff hist +79 Editing test page 2
- 22:34, 27 February 2023 diff hist +6 Editing test page 2
- 22:33, 27 February 2023 diff hist +16 Editing test page 2
- 22:03, 13 February 2023 diff hist -8 Neuroblastoma - historical →Maintenance, Not eligible for myeloablative therapy
- 22:03, 13 February 2023 diff hist -36 Neuroblastoma - historical →Consolidation, Eligible for myeloablative therapy
- 22:02, 13 February 2023 diff hist +2 Neuroblastoma - historical →Maintenance, Post Consolidation Isotretinoin
- 22:01, 13 February 2023 diff hist +2 Neuroblastoma - historical →Maintenance, Post Maintenance Isotretinoin
- 21:59, 13 February 2023 diff hist +19 Neuroblastoma - historical →Maintenance, Isotretinoin
- 21:59, 13 February 2023 diff hist +12 Neuroblastoma - historical →Post-maintenance, Isotretinoin
- 21:54, 13 February 2023 diff hist +5 Neuroblastoma - historical →Maintenance, Isotretinoin
- 21:47, 13 February 2023 diff hist +2 Neuroblastoma - historical →COG A3973 without Myeloablative Therapy
- 20:46, 13 February 2023 diff hist -1 Neuroblastoma - historical →=Chemotherapy, 3 Cycles
- 20:46, 13 February 2023 diff hist +1,088 Neuroblastoma - historical →References
- 20:45, 13 February 2023 diff hist +1,088 Neuroblastoma - historical →References
- 20:45, 13 February 2023 diff hist -429 Neuroblastoma →References
- 20:44, 13 February 2023 diff hist +429 Neuroblastoma →References
- 20:35, 13 February 2023 diff hist +8,861 Neuroblastoma - historical →COG A3973
- 19:31, 13 February 2023 diff hist +15 Neuroblastoma - historical
- 21:51, 23 January 2023 diff hist -2 Neuroblastoma →Chemotherapy, Tandem HSCT #2 (CEM)
- 21:50, 23 January 2023 diff hist +2 Neuroblastoma →Chemotherapy, Tandem HSCT #2 (CEM)
- 21:16, 23 January 2023 diff hist -2 Neuroblastoma →Chemotherapy, Tandem HSCT #2 (CEM)
- 21:15, 23 January 2023 diff hist +1 Neuroblastoma →Chemotherapy, Tandem HSCT #2 (CEM)
- 21:13, 23 January 2023 diff hist -1 Neuroblastoma →References
- 21:12, 23 January 2023 diff hist +1,305 Neuroblastoma →References
- 21:00, 23 January 2023 diff hist +1,449 Neuroblastoma →Post-Consolidation
- 20:52, 23 January 2023 diff hist +3,961 Neuroblastoma →COG ANBL17P1
- 20:47, 23 January 2023 diff hist +611 Neuroblastoma →Chemotherapy, Tandem HSCT #2 (CEM)
- 20:37, 23 January 2023 diff hist 0 Neuroblastoma →Chemotherapy, Tandem HSCT #2 (CEM)
- 20:37, 23 January 2023 diff hist +335 Neuroblastoma →Chemotherapy, Tandem HSCT #2 (CEM)
- 20:32, 23 January 2023 diff hist +2,341 Neuroblastoma →COG ANBL17P1
- 20:18, 23 January 2023 diff hist +10 Neuroblastoma →COG ANBL 0032 Regimen B
- 20:16, 23 January 2023 diff hist +36 Neuroblastoma →Induction, TOPO/CPM
- 20:13, 23 January 2023 diff hist +7,186 Neuroblastoma →COG ANBL17P1
- 19:41, 23 January 2023 diff hist +458 Neuroblastoma →Induction, CDDP/ETOP/DIN/GM-CSF